» Articles » PMID: 10491414

The Natural History of Insulin Secretory Dysfunction and Insulin Resistance in the Pathogenesis of Type 2 Diabetes Mellitus

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1999 Sep 24
PMID 10491414
Citations 557
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.

Citing Articles

Sub-Clinical Regional Macular Changes in Self-Reported Diabetic Subjects: Vascular and Retinal Layer Analysis Using Swept-Source OCT.

Challa N, Alghamdi W, Alluwimi M, Alshammeri S Diabetes Metab Syndr Obes. 2025; 18:363-372.

PMID: 39931374 PMC: 11809218. DOI: 10.2147/DMSO.S504882.


12-Lipoxygenase inhibition improves glucose homeostasis and obesity-associated inflammation in human gene replacement mice.

Kaylan K, Nargis T, Figatner K, Wang J, Pratuangtham S, Chakraborty A bioRxiv. 2025; .

PMID: 39868153 PMC: 11761697. DOI: 10.1101/2025.01.10.632274.


Marital status and risk of type 2 diabetes among middle-aged and elderly population: a systematic review and meta-analysis.

Karimi M, Binaei S, Hashemi S, Refahi P, Olama E, Olama E Front Med (Lausanne). 2025; 11():1485490.

PMID: 39830378 PMC: 11739031. DOI: 10.3389/fmed.2024.1485490.


Exploring the potential role of C-peptide in type 2 diabetes management.

Lin Y, McCrimmon R, Pearson E Diabet Med. 2025; 42(3):e15469.

PMID: 39797595 PMC: 11823364. DOI: 10.1111/dme.15469.


Irisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology.

Paoletti I, Coccurello R Int J Mol Sci. 2025; 25(24.

PMID: 39769243 PMC: 11676223. DOI: 10.3390/ijms252413480.


References
1.
Schwartz M, Boyko E, Kahn S, Ravussin E, Bogardus C . Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab. 1995; 80(5):1571-6. DOI: 10.1210/jcem.80.5.7745002. View

2.
Abbott W, Howard B, Ruotolo G, Ravussin E . Energy expenditure in humans: effects of dietary fat and carbohydrate. Am J Physiol. 1990; 258(2 Pt 1):E347-51. DOI: 10.1152/ajpendo.1990.258.2.E347. View

3.
Martin B, Warram J, Krolewski A, Bergman R, Soeldner J, Kahn C . Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992; 340(8825):925-9. DOI: 10.1016/0140-6736(92)92814-v. View

4.
Kadowaki T, Miyake Y, Hagura R, Akanuma Y, KAJINUMA H, Kuzuya N . Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 1984; 26(1):44-9. DOI: 10.1007/BF00252262. View

5.
Pimenta W, Mitrakou A, Jensen T, Yki-Jarvinen H, Daily G, Gerich J . Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabet Med. 1996; 13(9 Suppl 6):S33-6. View